Comment on

• 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

  Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, Vaysbrot E, McNaughton C, Osani M, Shmerling RH, Curtis JR, Furst DE, Parks D, Kavanaugh A, O'Dell J, King C, Leong A, Matteson EL, Schousboe JT, Drevlow B, Ginsberg S, Grober J, St Clair EW, Tindall E, Miller AS, McAlindon T. Singh JA, et al. Arthritis Rheumatol. 2016 Jan;68(1):1-26. doi: 10.1002/art.39480. Epub 2015 Nov 6. Arthritis Rheumatol. 2016. PMID: 26545940 Review.
• The Use of Low-Dose Oral Glucocorticoids Was Minimized in the 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis: Comment on the Article by Singh et al.

  Conn DL. Conn DL. Arthritis Rheumatol. 2016 May;68(5):1314. doi: 10.1002/art.39634. Arthritis Rheumatol. 2016. PMID: 26866310 No abstract available.
• The 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Should Include New Standards for Hepatitis B Screening: Comment on the Article by Singh et al.

  Calabrese LH, Calabrese C, Kirchner E. Calabrese LH, et al. Arthritis Rheumatol. 2016 May;68(5):1314-5. doi: 10.1002/art.39635. Arthritis Rheumatol. 2016. PMID: 26866423 No abstract available.
• Recommendations in the American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Related to the Use of Biologic Agents in Patients With a History of Cancer Need Reconsideration: Comment on the Article by Singh et al.

  Yazici H, Ozguler Y, Hatemi G, Yazici Y. Yazici H, et al. Arthritis Rheumatol. 2016 May;68(5):1315-6. doi: 10.1002/art.39633. Arthritis Rheumatol. 2016. PMID: 26867149 No abstract available.